Nowosinska E

No ORCID on file · 1 paper in corpus
2010
Cancer biomarkers : section A of Disease markers ·doi:10.3233/cbm-2011-0219

In the clinical setting the vast majority of positron emission tomography (PET) procedures use the glucose analogue F-18 fluorodeoxyglucose (FDG) to visualize the increased glucose consumption of malignant lesions. Co-registered PET/CT has …